Peter Bacher

792 total citations
35 papers, 571 citations indexed

About

Peter Bacher is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Peter Bacher has authored 35 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 13 papers in Internal Medicine and 10 papers in Surgery. Recurrent topics in Peter Bacher's work include Venous Thromboembolism Diagnosis and Management (13 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Blood Pressure and Hypertension Studies (6 papers). Peter Bacher is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (13 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Blood Pressure and Hypertension Studies (6 papers). Peter Bacher collaborates with scholars based in United States, Germany and Denmark. Peter Bacher's co-authors include Jawed Fareed, James R. Sowers, Mark E. Molitch, George L. Bakris, Kaffa Fakouhi, Jeanine M. Walenga, Pantelis Sarafidis, Mark Kipnes, Ann C. Hewkin and Annette Champion and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Peter Bacher

35 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Bacher United States	15	262	161	146	137	113	35	571
İstemihan Tengiz Türkiye	15	370 1.4×	196 1.2×	153 1.0×	31 0.2×	37 0.3×	58	722
Maria Domenica Guglielmi Italy	12	309 1.2×	78 0.5×	42 0.3×	38 0.3×	41 0.4×	24	530
Lena Norlund Sweden	10	95 0.4×	197 1.2×	55 0.4×	99 0.7×	198 1.8×	23	620
Biagio De Simone Italy	7	292 1.1×	87 0.5×	147 1.0×	111 0.8×	34 0.3×	8	614
Linda Woolf United Kingdom	6	210 0.8×	110 0.7×	106 0.7×	131 1.0×	426 3.8×	7	853
Marian Wald Myers United States	9	86 0.3×	54 0.3×	380 2.6×	128 0.9×	123 1.1×	15	746
Michele Arcopinto Italy	17	478 1.8×	124 0.8×	417 2.9×	131 1.0×	33 0.3×	41	997
D Felmeden United Kingdom	13	314 1.2×	102 0.6×	78 0.5×	33 0.2×	52 0.5×	26	567
Thanh-Tam Guyene France	7	311 1.2×	53 0.3×	353 2.4×	16 0.1×	24 0.2×	8	638
James E. Lang United States	11	60 0.2×	166 1.0×	167 1.1×	15 0.1×	50 0.4×	12	497

Countries citing papers authored by Peter Bacher

Since Specialization

Citations

This map shows the geographic impact of Peter Bacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bacher more than expected).

Fields of papers citing papers by Peter Bacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bacher. The network helps show where Peter Bacher may publish in the future.

Co-authorship network of co-authors of Peter Bacher

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bacher. A scholar is included among the top collaborators of Peter Bacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bacher. Peter Bacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luna, Manuel Sánchez, Peter Bacher, Kristina Unnebrink, Marisol Martinez‐Tristani, & Cristina Ramos‐Navarro. (2020). Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials. Journal of Perinatology. 40(8). 1121–1134. 13 indexed citations

Bacher, Peter, et al.. (2012). Safety and tolerability of intermittent androgen deprivation therapy: A literature review. International Journal of Urology. 19(7). 614–625. 18 indexed citations

Bakris, George L., Mark E. Molitch, Qian Zhou, et al.. (2008). Reversal of Diuretic‐Associated Impaired Glucose Tolerance and New‐Onset Diabetes: Results of the STAR‐LET Study. PubMed. 3(1). 18–25. 15 indexed citations

Toto, Robert D., Min Tian, Kaffa Fakouhi, Annette Champion, & Peter Bacher. (2008). Effects of Calcium Channel Blockers on Proteinuria in Patients With Diabetic Nephropathy. Journal of Clinical Hypertension. 10(10). 761–769. 19 indexed citations

Maggioni, Aldo P., Ian D. Caterson, Walmir Coutinho, et al.. (2008). Tolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial. Journal of Cardiovascular Pharmacology. 52(5). 393–402. 16 indexed citations

Bangalore, Sripal, Franz H. Messerli, Jerome D. Cohen, et al.. (2008). Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy. American Heart Journal. 156(2). 241–247. 35 indexed citations

Walenga, Jeanine M., Walter Jeske, Margaret Prechel, Peter Bacher, & Mamdouh Bakhos. (2004). Decreased Prevalence of Heparin-Induced Thrombocytopenia with Low-Molecular-Weight Heparin and Related Drugs. Seminars in Thrombosis and Hemostasis. 30. 69–80. 31 indexed citations

Massicotte, Patricia, Jim A. Julian, Velma Marzinotto, et al.. (2003). Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin–sodium) in pediatric patients. Thrombosis Research. 109(2-3). 93–99. 39 indexed citations

Ahmad, Sarfraz, Sylvia Haas, Debra A. Hoppensteadt, et al.. (2002). Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies. Thrombosis Research. 108(1). 49–55. 24 indexed citations

10.

Bacher, Peter, et al.. (1995). Evaluation of Hemostatic and Fibrinolytic Alterations Associated with Daily Administration of Low-Molecular-Weight Heparin for a 12-Week Period. Seminars in Thrombosis and Hemostasis. 21(2). 228–239. 13 indexed citations

11.

Callas, Demetra, Peter Bacher, & J. Fareed. (1995). Studies on the Thrombogenic Effects of Recombinant Tissue Factor. Seminars in Thrombosis and Hemostasis. 21(2). 166–176. 3 indexed citations

12.

Callas, Demetra, Peter Bacher, Omer Iqbal, Debra Hoppensteadt, & Jawed Fareed. (1994). Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin. Thrombosis Research. 74(3). 193–205. 19 indexed citations

13.

Bacher, Peter. (1993). Medical and surgical uses of recombinant hirudin: an international discussion forum. Munich, Germany, June 26, 1991.. PubMed. 19 Suppl 1. 210–6. 1 indexed citations

14.

Callas, Demetra, D. Hoppensteadt, Walter Jeske, et al.. (1993). Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide.. PubMed. 19 Suppl 1. 49–57. 21 indexed citations

15.

Bacher, Peter, Jeanine M. Walenga, Omer Iqbal, et al.. (1993). The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models. Thrombosis Research. 71(4). 251–263. 9 indexed citations

16.

Bacher, Peter, et al.. (1993). Modulation of endothelial and platelet function by a polydeoxyribonucleotide derived drug “defibrotide”. A dual mechanism in the control of vascular pathology. Thrombosis Research. 70(4). 343–348. 10 indexed citations

17.

Fareed, Jawed, Peter Bacher, Harry L. Messmore, et al.. (1992). Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs. Progress in Cardiovascular Diseases. 34(6). 379–398. 9 indexed citations

18.

Bacher, Peter, D. Welzel, Omer Iqbal, et al.. (1992). The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model. Thrombosis Research. 66(2-3). 151–158. 19 indexed citations

19.

Hubbard, Tim, et al.. (1991). Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit model. Blood Coagulation & Fibrinolysis. 2(1). 101–104. 5 indexed citations

20.

Fareed, Jawed, Jeanine M. Walenga, Fred Leya, et al.. (1991). Some Objective Considerations for the Use of Heparins and Recombinant Hirudin in Percutaneous Transluminal Coronary Angioplasty. Seminars in Thrombosis and Hemostasis. 17(4). 455–470. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact